FDA Extends Comment Period for Proposed Rules on Human Subjects Protection and Cooperative Research

Summary

The Food and Drug Administration (FDA) is extending the comment period for two proposed rules regarding human subjects protection and institutional review boards, and cooperative research. The FDA is seeking additional comments from interested persons to allow more time to review the proposed changes.